DrSergio Coutinho Furtado Mendonca

Phase I-II studies with BIOBRAS GMP produced single-strain vaccine against leishmaniasis

American tegumentary leishmaniasis: evaluation of antigenicity and immunogenicity of vaccine candidates

Obtain/characterize T cell lines and clones from blood and lesion reactive to Leishmania-antigen fractions

Study of kinetics of the human T cell response to antigenic fractions of Leishmania

Examine whether anti-idiotypic antibodies can activate T lymphocytes specific for leish & upon injection in normal mice